Financial Advisors Network Inc. raised its holdings in Colgate-Palmolive (NYSE:CL) by 31.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,031 shares of the company’s stock after buying an additional 1,431 shares during the quarter. Financial Advisors Network Inc.’s holdings in Colgate-Palmolive were worth $455,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of CL. Jacobi Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares during the period. Krilogy Financial LLC grew its holdings in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the period. Captrust Financial Advisors purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $122,000. AlphaMark Advisors LLC grew its holdings in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the period. Finally, Bruderman Asset Management LLC purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $126,000. Institutional investors own 71.52% of the company’s stock.
In other Colgate-Palmolive news, COO Noel R. Wallace sold 126,304 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total value of $9,318,709.12. Following the transaction, the chief operating officer now directly owns 305,631 shares of the company’s stock, valued at approximately $22,549,455.18. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP John J. Huston sold 14,000 shares of the company’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $69.44, for a total value of $972,160.00. Following the completion of the transaction, the senior vice president now directly owns 100,508 shares in the company, valued at $6,979,275.52. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 421,019 shares of company stock worth $30,031,097. 1.02% of the stock is currently owned by corporate insiders.
A number of analysts have recently issued reports on the company. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a report on Monday, January 8th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price for the company in a report on Tuesday, December 19th. BNP Paribas cut Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Citigroup upped their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Tuesday, January 30th. Finally, Deutsche Bank assumed coverage on Colgate-Palmolive in a report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price target for the company. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have assigned a buy rating to the company. Colgate-Palmolive has an average rating of “Hold” and an average target price of $77.91.
Colgate-Palmolive (NYSE CL) opened at $71.46 on Tuesday. The firm has a market capitalization of $62,750.00, a P/E ratio of 27.59, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75. Colgate-Palmolive has a fifty-two week low of $68.19 and a fifty-two week high of $77.91. The company has a debt-to-equity ratio of 27.02, a current ratio of 1.36 and a quick ratio of 1.00.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter in the prior year, the business earned $0.75 EPS. Colgate-Palmolive’s quarterly revenue was up 4.6% compared to the same quarter last year. equities analysts forecast that Colgate-Palmolive will post 3.18 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd were given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend was Monday, January 22nd. Colgate-Palmolive’s payout ratio is 61.78%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.